Semi-Annual Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7539631

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Semi-annual statement of income
Statement of income
Net sales
44,000 JPY
179,000 JPY
Cost of sales
11,000 JPY
44,000 JPY
Ordinary profit (loss)
-551,566,000 JPY
-809,792,000 JPY
Gross profit (loss)
33,000 JPY
134,000 JPY
Selling, general and administrative expenses
550,603,000 JPY
805,202,000 JPY
Extraordinary losses
1,406,000 JPY
JPY
Selling, general and administrative expenses
Operating profit (loss)
-550,569,000 JPY
-805,068,000 JPY
Profit (loss) before income taxes
-552,972,000 JPY
-809,792,000 JPY
Income taxes - current
950,000 JPY
950,000 JPY
Non-operating income
193,000 JPY
557,000 JPY
Non-operating income
Interest income
6,000 JPY
11,000 JPY
Income taxes
950,000 JPY
950,000 JPY
Non-operating expenses
1,190,000 JPY
5,281,000 JPY
Profit (loss)
-553,922,000 JPY
-810,742,000 JPY
Non-operating expenses
Extraordinary losses
Impairment losses
1,406,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.